Citadel Advisors
HSCSW icon

Citadel Advisors’s HeartSciences Inc Warrant HSCSW Stock Holding History

Citadel Advisors’s Portfolio HSCSW Stock Details HSCSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22K Sell
192,587
-2,972
-2% -$281 ﹤0.01% 12654
2025
Q4 		$8.82K Sell
195,559
-18,539
-9% -$1.42K ﹤0.01% 12438
2025
Q3 		$29.8K Sell
214,098
-9,421
-4% -$1.01K ﹤0.01% 12397
2025
Q2 		$20.4K Sell
223,519
-1,290
-0.6% -$94 ﹤0.01% 12102
2025
Q1 		$11K Buy
224,809
+10,652
+5% +$471 ﹤0.01% 13515
2024
Q4 		$6.45K Sell
214,157
-6,271
-3% -$236 ﹤0.01% 13794
2024
Q3 		$9.68K Sell
220,428
-3,900
-2% -$165 ﹤0.01% 13242
2024
Q2 		$11K Buy
224,328
+195,750
+685% +$7.4K ﹤0.01% 13058
2024
Q1 		$1.43K Sell
28,578
-400
-1% -$26 ﹤0.01% 14132
2023
Q4 		$2.32K Buy
28,978
+813
+3% +$52 ﹤0.01% 13710
2023
Q3 		$1.41K Buy
28,165
+14,316
+103% +$1.58K ﹤0.01% 13871
2023
Q2 		$2.17K Buy
13,849
+3,639
+36% +$652 ﹤0.01% 13816
2023
Q1 		$2.3K Sell
10,210
-17,944
-64% -$4.3K ﹤0.01% 14169
2022
Q4 		$7.67K Buy
+28,154
New +$9.39K ﹤0.01% 13809

Other funds holding HSCSW

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's HSCSW Position: Q1 2026 in Review

Citadel Advisors reduced its HeartSciences Inc Warrant (HSCSW) stake by 1.5% in Q1 2026, selling an estimated $281 and leaving 192,587 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #12654.

Citadel Advisors first reported a position in HSCSW in Q4 2022 and has held it in 14 quarters since. The position peaked at $29.8K in Q3 2025. 3 funds tracked by Wall St. Rank hold HSCSW as of Q1 2026.

  • Citadel Advisors held 192,587 shares of HeartSciences Inc Warrant worth $22K as of Q1 2026.
  • Citadel Advisors sold 2,972 HeartSciences Inc Warrant shares in Q1 2026, an estimated $281.
  • HeartSciences Inc Warrant made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12654 holding.
  • Citadel Advisors first reported a position in HeartSciences Inc Warrant in Q4 2022 and has held it in 14 quarters since.
  • Citadel Advisors's HeartSciences Inc Warrant position peaked at $29.8K in Q3 2025.
  • 3 funds tracked by Wall St. Rank held HeartSciences Inc Warrant as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.